Next-Generation Brand Planning: (Unexpected) Worrying Trends Demand a Rethink on Brand Planning

02|10|25

The Power of Data and Machine Learning to Optimize HCP Prescription Volume

In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.

02|10|25

Creating Award-Winning Work: Insights From Susan Perlbachs With Muse by Clios

In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.

02|10|25

2025 Data Privacy Landscape: Is Pharma Ready for the Scrutiny?

In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more.